The same Scandinavian man shown lean and energetic beside a heavier, fatigued version

Workup with no GP referral

Low testosterone? Workup, blood test and TRT with no referral

Fatigue, brain fog or belly fat that will not move? Start with a free symptom test — or go straight to blood work.

Choose blood tests

EU telemedicine. Prescription after work-up and medical assessment of symptoms and blood tests.

  • No GP referral
  • Fast workup
  • Prescription only if indicated
  • Pharmacy or shipped
Are you experiencing these markers?

Average male testosterone has more than halved across five decades.

The fall appears across independent cohorts in the US, Denmark and Finland, it shows no sign of flattening, and no European government measures it or raises the alarm. The consequences are wide: insulin resistance, weight gain, type 2 diabetes, muscle loss, osteoporosis, low mood or depression and premature ageing — in the young as well as the old.

Systemic fatigue and energy drop

Often the first thing men notice. It is easy to write off as work or age, and it is a reason to measure, not to guess.

Brain fog and low drive

Poorer concentration and a flatter sense of drive. Several causes exist. A hormone panel shows whether testosterone is one of them.

Metabolism and insulin resistance

Worse glucose handling and a higher measured risk of type 2 diabetes in men with low testosterone. The blood test is the next step.

Visceral fat and muscle loss

Abdominal fat and loss of muscle. Fat tissue converts testosterone, which can deepen the problem. Measure before you decide.

Sexual symptoms

Lower libido, fewer morning erections, weaker erectile firmness. Zitzmann 2006 linked the first of these to levels around 15 nmol/L.

Don't guess. Measure.

Clinical replacement starts with a validated assessment. Take the free symptom questionnaire and get an indication now, before you order a test.

01 — The epidemic

Once upon a time… Young and old had high T, throughout life.

Total and free testosterone across adulthood: the healthy-young reference range versus today's population average. Some symptoms attributed to getting older can have a hormonal cause, which is why measurement matters.

−54%

Average testosterone, 1972–2019 · 118,593 men in five countries (ESHRE 2026 pooled conference analysis).

−37%

Same-age difference: 21.9 to 13.8 nmol/L in Finnish men aged 60–69 (3,271 men; Perheentupa et al. 2013).

15–39 yrs

The decline also reaches adolescents and young adults and remained significant at normal BMI (NHANES; Lokeshwar et al. 2020/2021).

A young man at 16 nmol/L is not 10 or 20 percent short of where young men sat. Men aged 25–29 in the Finnish data averaged about 25 nmol/L (Perheentupa et al. 2013). From 16 that is about a 60 percent rise, just to reach that average. Double, about 32 nmol/L, is only the upper end of the healthy young range (Travison et al. 2017).

Clinical context

Total Testosterone vs. Symptom Ranges

Hover or focus a point for age, level and both unit systems.

0092601851927779361038451298203040506070nmol/Lng/dL
Historical upper reference: 97.5th percentile, healthy men 19–40 (Framingham, Bhasin 2011)Historical mean, healthy young men 19–40 (Framingham, Bhasin 2011)Upper modern standardPresent-day population mean (MMAS, Travison 2007)

Early / individual symptoms13–19 nmol/L · 375–548 ng/dLZitzmann et al. (2006) found the first symptom associations around 15 nmol/L: reduced libido, declining vigor and energy, weaker morning erections, poorer recovery after exercise, lower motivation and flatter mood. Symptoms are individual and relate to the fall from your own younger baseline — not a fixed cut-off.

Sexual symptoms become more likely11–13 nmol/L · 317–375 ng/dLBelow ~12–13 nmol/L the associations widen in Zitzmann et al. (2006) and EMAS: markedly reduced sex drive, erectile dysfunction, absent morning erections, reduced physical strength and endurance, growing belly fat, difficulty building or maintaining muscle, and increasing insulin resistance / prediabetic drift.

Marked deficiency range< 11 nmol/L · < 317 ng/dLBelow ~10–11 nmol/L every symptom group becomes strong and clustered: weight gain and increased fat mass (especially abdominal), loss of muscle mass and strength, metabolic problems including type 2 diabetes and metabolic syndrome, loss of bone density (osteoporosis), depression and low mood, chronic fatigue, sleep problems, hot flushes, reduced cognitive performance — and severely reduced libido, erection strength and fertility. This is the range where the hypogonadal-obesity cycle takes over: low T drives fat gain, and fat aromatises testosterone away, deepening the deficiency.

The two historical lines come from a measured cohort: the 97.5th percentile and the mean of healthy non-obese men aged 19-40 measured by LC-MS/MS in the Framingham Heart Study (Bhasin et al. 2011), extended across age with the Baltimore Longitudinal Study age slope (Harman et al. 2001). The two modern lines are the upper modern standard and the present-day population mean (MMAS, Travison et al. 2007). No verified hormone measurements exist from before the mid-20th century. Symptom zones follow the threshold associations mapped by Zitzmann et al. (2006), Scovell et al. (2015) and EMAS. Symptoms are individual and relative to your own younger baseline — only a blood test shows where you sit on this chart.
See all charts, bone density and diabetes outcomes →

Blood tests

Do I need my doctor to approve the blood test?
No. You order the panel yourself. Men typically come here for reasons like these: their doctor said no, they will not wait, or they want a hormone specialist in the EU this week. Your own doctor can still see the result. That is your choice, not the way in. A prescription follows a consultation, and only when treatment is indicated.
Have the lab methods just changed?
No. In the Janus Serum Bank, blood from men aged 40–49 had been frozen for up to 29 years. Gislefoss et al. (2012) ran it on both an immunoassay and LC-MS/MS. The oldest samples were substantially higher than fresh ones. Storage breaks hormone down, so it would have made the old numbers lower, not higher.
I have a number. What now?
Put it next to your symptoms, not next to a laboratory’s “normal for your age.” Zitzmann et al. (2006) saw the first symptom links around 15 nmol/L. Sexual symptoms become more common below about 11–12 (EMAS, Wu et al. 2010). A specialist reads the two together.
What the researchers actually wrote.

The hypogonadal obesity cycle

Type 2 diabetes and metabolic syndrome are downstream problems that researchers describe as a consequence of low testosterone. First it becomes difficult or impossible to maintain muscle mass and body weight; fat mass increases, especially around the abdomen — which then suppresses testosterone further. Researchers call this vicious circle the hypogonadal obesity cycle.

In observational registries, some treated men with deficiency and type 2 diabetes reached remission, and the randomised T4DM trial found fewer cases of type 2 diabetes after two years with testosterone than with lifestyle measures alone. These results apply to men with confirmed deficiency. They do not mean that all men with type 2 diabetes should be treated, and higher doses are not better.

Read the full evidence index →
  1. 1

    Testosterone falls below the symptom threshold — energy, drive and training capacity decline first.

  2. 2

    Muscle mass becomes hard to maintain and resting metabolic rate falls.

  3. 3

    Fat mass increases, concentrated around the abdomen.

  4. 4

    Abdominal fat is rich in aromatase, converting testosterone into estradiol and suppressing the signal to produce more.

  5. 5

    Lower testosterone again — insulin resistance, higher fasting glucose and eventually type 2 diabetes.

  6. The hypogonadal obesity cycle
03 — The benefits

In studies, higher testosterone is associated with:

These associations come from studies of men with confirmed deficiency. Treatment is not a general anti-ageing measure, and results vary between men.

Visceral fat reduction

In treated deficiency, studies have reported reductions in fat mass and waist circumference alongside lifestyle measures.

Muscle mass & bone density

In dose–response studies, lean mass and strength increased with the achieved hormone level. In older men the effects on muscle function have been modest.

Insulin sensitivity

In a small clamp study, tissue glucose uptake in response to insulin rose by 32–35% with treatment of hypogonadism.

Diabetes remission

In an observational registry with up to 11 years of follow-up, approximately 34% of treated hypogonadal men with type 2 diabetes reached remission. A registry cannot prove cause and effect.

Cognition & mood

Low drive, poor concentration and low mood can have hormonal causes, but also many others, such as stress or depression.

Cardiometabolic resilience

Low testosterone is associated with visceral fat, low-grade inflammation and insulin resistance. Whether treatment changes this is assessed individually.

04 — Your pathway

Take the international questionnaire and get your answer immediately.

1
STEP 1

The international symptom test

Two minutes, answered instantly. It maps your symptoms against the domains that track free testosterone.

2
STEP 2

Finger-prick kit at home, or a venous draw at a clinic

A blood test is required so the endocrinologist can see your free testosterone and relevant markers, and relate them to your symptoms.

3
STEP 3

Consultation and prescription

When you have your blood results, we can book a consultation where the endocrinologist concludes on your symptoms and labs — and if treatment is indicated and you want it, it is started and you agree the form of testosterone (cream, subcutaneous or IM).

What the researchers actually wrote.

Three papers explain most of what men are told is simply age: where symptoms begin, which ones are often felt first, why there is no single cut-off, and what happens to type 2 diabetes when the deficiency is corrected.

Lack of energy appears to be the most important symptom that predicts a total testosterone level of 400 ng/dL (14 nmol/L) or below.

Scovell et al. found that symptoms of low testosterone in young men, appear at a serum total testosterone threshold of 400 ng/dL (14 nmol/L) — well above the cut-off most European laboratories use. Alongside lack of energy was sadness, decreased strength and endurance, decreased ability to play sports and deterioration in work performance, which were most strongly predictive of low testosterone.

Scovell J. M. et al., BJU International, 2015
Prevalence of psychosomatic symptoms and metabolic risk factors accumulated with decreasing androgentestosterone levels. For example, prevalence of loss of libido or vigour, increased below testosterone concentrations of 15 nmol/L (P < 0.001), whereas depression and diabetes type 2 (also in non-obese men) were significantly more present in men with testosterone concentrations below 10 nmol/L.

Zitzmann et al. widen the threshold further: the first symptoms appeared around 15 nmol/L, but the authors note there was no clear-cut boundary — some men experience symptoms earlier than others. Cluster analysis revealed ageing men to present within three independent groups, characterised by 1) psychosomatic complaints 2) metabolic disorders 3) sexual health problems

Zitzmann, Faber & Nieschlag, Institute of Reproductive Medicine, University of Münster — J Clin Endocrinol Metab 91: 4335–4343, 2006
Testosterone therapy is potentially a novel additional therapy for men with type 2 diabetes and hypogonadism.

Haider et al. followed 356 men with type 2 diabetes and testosterone below 350 ng/dL (12.1 nmol/L); 178 men received long-acting testosterone therapy prescribed by their physician. Treated patients showed significant, progressive and sustained reductions in both fasting glucose, HbA1c and fasting insulin. 34.3% achieved full remission of their diabetes and 46.6% achieved normal glucose regulation. In the testosterone group 83% reached the HbA1c target of 47.5 mmol/mol (6.5%) and 90% the target of 53 mmol/mol (7%).

Haider K. S. et al., 'Remission of type 2 diabetes following long-term treatment with injectable testosterone undecanoate in patients with hypogonadism and type 2 diabetes: 11-year data from a real-world registry study', Diabetes, Obesity and Metabolism, 2020
“For decades, low testosterone was ignored or feared. The real medical threat isn't restoring healthy levels; it's letting men suffer in silence with low testosterone.”
Dr. Abraham Morgentaler — Urologist and Harvard professor
The reference point has quietly moved.

Laboratory “normal” ranges are drawn from a declining population. Measured against healthy non-obese young men in the Framingham cohort (Bhasin et al. 2011), today's average man sits far down that distribution.

PeriodTotal T averageTotal T, healthy young referenceFree T averageFree T, healthy young reference
1987–89 · MMAS (Travison 2007)17.4 nmol/Lup to 41.5 nmol/L in healthy young men350 pmol/L—
1995–97 · MMAS follow-up15.6 nmol/L—310 pmol/L—
2002–04 · MMAS / NHANES onwards13.6 nmol/L—270 pmol/L—

Where do your symptoms sit?

Symptoms correlate far more strongly with free testosterone than with total testosterone — the finding most standard consultations still miss.

27 – 42+ nmol/L
780 – 1200+ ng/dL
Upper reference range, healthy young men
Free T: 450 – 650 pmol/L

Upper part of the reference data for healthy young men. A reference position, not a treatment target.

18 – 27 nmol/L
520 – 780 ng/dL
Normal
Free T: 300 – 450 pmol/L

Within the usual laboratory reference range.

12 – 18 nmol/L
350 – 520 ng/dL
Borderline (subclinical)
Free T: 200 – 300 pmol/L

Grey zone: symptoms such as fatigue are reported more often here, but the number alone does not make a diagnosis.

< 12 nmol/L
< 350 ng/dL
Clinically low
Free T: ~150 pmol/L

Below common laboratory limits. A diagnosis requires symptoms and a repeat measurement.

Already in treatment?

Fluctuating results or rising haematocrit?

If your protocol peaks around 20 nmol/L and drops close to 10 before the next injection, you may be one of those who feel the trough more than the treatment, and watch old symptoms return before the next shot. If you want a second opinion, our physicians will review your options with fresh eyes. Ask about clean-label testosterone for subcutaneous use.

Get a second opinion →

For women

Women lost the same baseline.

Oestrogen falls up to 90% through menopause while testosterone falls roughly 50% — reshaping the ratio that governs bone density, muscle tone, cognition and libido. See the female charts, the free testosterone symptom bands and how a physician assesses hormone levels.

Women's hormonal status →
“Treat the patient, not the paper. A blood test gives you a number, but the man sitting in front of you gives you the reality.”
Dr. Keith Nichols — Physician and TRT specialist